ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

Report Urges NCI To Continue 5 A Day, Expand Funding For Communications.

February 9, 2001

First Test Of Cooperative Groups’ Willingness To Change Coming In New Colorectal Trials

November 14, 1986

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

Shubick Blasts Tobacco Industry Scientists

October 4, 1974